{"relation": [["Conditions", "Lung", "Lung", "Lung", "Lung", "Lung"], ["Study Title", "A Phase Ib Study of the Safety and Pharmacology of MPDL3280A administered with Erlotinib or Alectinib in Patients with Advanced Non-Small Cell Lung Cancer", "A Phase II, Non-comparative, Open label, Multi-centre, International Study of MEDI4736, in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Stage IIIB-IV) who have received at least Two Prior Systemic Treatment Regimens Including One Platinum-based Chemotherapy Regimen (ATLANTIC)", "A Phase 2, Multicenter, Single-arm Study of Oral AP26113 in Patients with ALK-positive, Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Who Have Previously Been Treated with Crizotinib", "A Phase 1 Study of MPDL3280A in Combination With INCB024360 in Subjects With Previously Treated Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer", "Expanded Access Single Named Patient Program for the Use of Nivolumab for a Patient (Initials R-C) with Non-Small Cell Lung Cancer"]], "pageTitle": "Scott Nicholas Gettinger, MD > Yale Cancer Center | Yale School of Medicine", "title": "", "url": "http://yalecancercenter.org/research/people/scott_gettinger-3.profile", "hasHeader": true, "headerPosition": "MIXED", "tableType": "RELATION", "tableNum": 0, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988650.53/warc/CC-MAIN-20150728002308-00022-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 863444591, "recordOffset": 863416840, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Clinical Trials Medical Oncology AB of Internal Medicine (2005) Board Certifications Yale Medical Group Internal Medicine: Medical Oncology: Subset Medical Oncology Faculty Cancer Center, Yale: Thoracic Oncology Program Patient Care Organizations Accepts new patients? Yes Patient Type: Adult Referrals: From patients or physicians Patient Care Medical Oncology Clinical Interests News Patient Care Biography Associate Professor Of Medicine (Medical Oncology) Scott Nicholas Gettinger, MD 18,7.7 \" /> c0-0.3,0-0.6,0.1-1c0.1-0.4,0.3-0.7,0.7-0.7c0.5-0.1,1.1-0.1,1.6,0c0.9,0.2,1.4,0.6,1.5,1.5c0.1,0.4,0.1,0.8,0.1,1.2 c0-0.4,0-0.8,0-1.2c-0.1,0-0.2,0-0.2,0c-0.4,0-0.8,0-1.3-0.1c-0.6-0.1-0.8-0.3-0.9-0.9c-0.1-0.4-0.1-0.9-0.1-1.3c0-2.5,0-5,0-7.6 c0,0.2,0,0.5,0,0.7c-0.1,0.6-0.3,0.9-1,1c-0.4,0.1-0.9,0-1.3,0c-0.1,0-0.1,0-0.2,0c0,0.4,0,0.8,0,1.2c2.3,0,4.6,0,7,0 c0.1-0.6,0.4-1.2,1.1-1.4c0.7-0.2,1.4-0.3,2.1-0.1C4.8,1.4,5.1,1.6,5.2,2c0.1,0.3,0.1,0.6,0.1,0.9c0,2.7,0,5.4,0,8.1 c0,0.2,0,0.4,0,0.5c0.4,0,0.8,0,1.2,0c0-1.5-0.1-3-0.1-4.5C8.3,0,4.2,0,0,0z\" /> c0-0.3,0-0.6,0.1-1c0.1-0.4,0.3-0.7,0.7-0.7c0.5-0.1,1.1-0.1,1.6,0c0.9,0.2,1.4,0.6,1.5,1.5c0.1,0.4,0.1,0.8,0.1,1.2 c0-0.4,0-0.8,0-1.2c-0.1,0-0.2,0-0.2,0c-0.4,0-0.8,0-1.3-0.1c-0.6-0.1-0.8-0.3-0.9-0.9c-0.1-0.4-0.1-0.9-0.1-1.3c0-2.5,0-5,0-7.6 c0,0.2,0,0.5,0,0.7c-0.1,0.6-0.3,0.9-1,1c-0.4,0.1-0.9,0-1.3,0c-0.1,0-0.1,0-0.2,0c0,0.4,0,0.8,0,1.2c2.3,0,4.6,0,7,0 c0.1-0.6,0.4-1.2,1.1-1.4c0.7-0.2,1.4-0.3,2.1-0.1C4.8,1.4,5.1,1.6,5.2,2c0.1,0.3,0.1,0.6,0.1,0.9c0,2.7,0,5.4,0,8.1 c0,0.2,0,0.4,0,0.5c0.4,0,0.8,0,1.2,0c0-1.5-0.1-3-0.1-4.5C8.3,0,4.2,0,0,0z\" /> c0-0.3,0-0.6,0.1-1c0.1-0.4,0.3-0.7,0.7-0.7c0.5-0.1,1.1-0.1,1.6,0c0.9,0.2,1.4,0.6,1.5,1.5c0.1,0.4,0.1,0.8,0.1,1.2 c0-0.4,0-0.8,0-1.2c-0.1,0-0.2,0-0.2,0c-0.4,0-0.8,0-1.3-0.1c-0.6-0.1-0.8-0.3-0.9-0.9c-0.1-0.4-0.1-0.9-0.1-1.3c0-2.5,0-5,0-7.6 c0,0.2,0,0.5,0,0.7c-0.1,0.6-0.3,0.9-1,1c-0.4,0.1-0.9,0-1.3,0c-0.1,0-0.1,0-0.2,0c0,0.4,0,0.8,0,1.2c2.3,0,4.6,0,7,0 c0.1-0.6,0.4-1.2,1.1-1.4c0.7-0.2,1.4-0.3,2.1-0.1C4.8,1.4,5.1,1.6,5.2,2c0.1,0.3,0.1,0.6,0.1,0.9c0,2.7,0,5.4,0,8.1", "textAfterTable": "Edit this profile Research & Education Members YCC Membership Portal Cancer Genetics and Genomics Cancer Immunology Developmental Therapeutics Molecular Virology Prevention & Control Radiobiology & Radiotherapy Signal Transduction Contact Info Scott Nicholas Gettinger, MD Appt203.200.5864 Appt Fax203.688.3501 Emailscott.gettinger@yale.edu Patient Care Location Yale Cancer Center Yale-New Haven Hospital 20 York Street, Ste North Pavilion 4 New Haven, CT 06510 Mailing Address PO Box 208028 New Haven, CT 06520-8028 MyChart Learn more & Signup Education Patient Care", "hasKeyColumn": false, "keyColumnIndex": -1, "headerRowIndex": 0}